BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 6437432)

  • 21. Simultaneous occurrence of clinical manifestations of myeloma and Waldenström's macroglobulinemia with monoclonal IgG Lambda and IgM Kappa in a single patient.
    Fine JM; Gorin NC; Gendre JP; Petitpierre JC; Labro-Bryskier MT; Lambin P
    Acta Med Scand; 1981; 209(3):229-34. PubMed ID: 6784449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biphenotypic plasma cell myeloma: two cases of plasma cell neoplasm with a coexpression of kappa and lambda light chains.
    Jiwani S; Bornhost J; Alapat D
    Int J Clin Exp Pathol; 2015; 8(7):8536-44. PubMed ID: 26339430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic significance of kappa/lambda and lambda/kappa ratio in paraproteinemias.
    Tichý M; Hrncír Z
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1982; 25(3-4):313-8. PubMed ID: 6820852
    [No Abstract]   [Full Text] [Related]  

  • 24. Monoclonal origin of B cells producing k, lambda and k lambda immunoglobulin light chains in a patient with chronic lymphocytic leukemia.
    del Senno L; Gandini D; Gambari R; Lanza F; Tomasi P; Castoldi G
    Leuk Res; 1987; 11(12):1093-8. PubMed ID: 2826930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in lymphocyte surface immunoglobulins in myeloma and the effect of an RNA-containing plasma factor.
    Chen Y; Bhoopalam N; Yakulis V; Heller P
    Ann Intern Med; 1975 Nov; 83(5):625-31. PubMed ID: 812401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bence Jones proteins and light chains of immunoglobulins. XIV. Conformational dependency and molecular localization of the kappa (kappa) and lambda (lambda) antigenic determinants.
    Solomon A
    Scand J Immunol; 1976; 5(6-7):685-95. PubMed ID: 62385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kappa/lambda ratios.
    Ault KA
    Diagn Immunol; 1986; 4(1):57-8. PubMed ID: 3082569
    [No Abstract]   [Full Text] [Related]  

  • 28. IgG-cryoglobulin consisting of both kappa and lambda light chains and beta 1C/1A.
    Arakawa M; Ono I; Ito S; Mihara A; Tashiro A
    Tohoku J Exp Med; 1979 Nov; 129(3):295-301. PubMed ID: 118545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flow cytometric light chain analysis of peripheral blood lymphocytes in patients with non-Hodgkin's lymphoma.
    Johnson A; Cavallin-Ståhl E; Akerman M
    Br J Cancer; 1985 Aug; 52(2):159-65. PubMed ID: 3927967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Determination of free kappa and lambda light chains in urine by immunoenzyme analysis].
    León VJ; León E; Martínez-Pescador R; López-Borrasca A
    Sangre (Barc); 1986; 31(3):311-6. PubMed ID: 3092374
    [No Abstract]   [Full Text] [Related]  

  • 31. An IgG M-component reacting with both anti-kappa and anti-gamma light chains in multiple myeloma.
    Onodera S; Inaba R; Sato I; Endo K; Suzuki T
    Tohoku J Exp Med; 1976 Nov; 120(3):269-75. PubMed ID: 825992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In situ hybridization detection of light chain mRNA in routine bone marrow trephines from patients with suspected myeloma.
    Akhtar N; Ruprai A; Pringle JH; Lauder I; Durrant ST
    Br J Haematol; 1989 Nov; 73(3):296-301. PubMed ID: 2513865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clonally restricted B cells in peripheral blood of multiple sclerosis patients: kappa/lambda staining patterns.
    Hauser SL; Weiner HL; Ault KA
    Ann Neurol; 1982 Apr; 11(4):408-12. PubMed ID: 6179457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple myeloma with monoclonal IgG and IgD of lambda type exhibiting, under treatment, a shift from mainly IgG to mainly IgD.
    Gallart T; Bladé J; Martínez-Quesada J; Sierra J; Rozman C; Vives J
    Immunology; 1985 May; 55(1):45-57. PubMed ID: 3922877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IgD myeloma protein with "unreactive" light chain determinants.
    Cejka J; Kithier K
    Clin Chem; 1979 Aug; 25(8):1495-8. PubMed ID: 88283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concentrations of Serum Free Light Chains in Kappa and Lambda Lesions in Light-Chain Myelomas.
    Singh G
    Lab Med; 2019 Apr; 50(2):189-193. PubMed ID: 30423164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Biclonal light chain gammopathy in multiple myeloma--a case report].
    Ogasawara T; Yasuyama M; Kawauchi K
    Nihon Rinsho Meneki Gakkai Kaishi; 2002 Apr; 25(2):170-6. PubMed ID: 12043184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoperoxidase staining of bone marrow sections.
    Hitzman JL; Li CY; Kyle RA
    Cancer; 1981 Dec; 48(11):2438-46. PubMed ID: 6794902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and distribution of B lineage cells in the domestic cat: analysis with monoclonal antibodies to cat mu-, gamma-, kappa-, and lambda-chains and heterologous anti-alpha antibodies.
    Klotz FW; Gathings WE; Cooper MD
    J Immunol; 1985 Jan; 134(1):95-100. PubMed ID: 3917286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isotypic discordance of paraproteins and lymphocyte surface immunoglobulins in myeloma.
    Nicholls M; Vincent PC; Repka E; Saunders J; Gunz FW
    Blood; 1981 Jan; 57(1):192-5. PubMed ID: 6778537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.